Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality
Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether intravenous iron supplementation using
ferric carboxymaltosis (FCM) reduces hospitalisation and mortality in patients with iron
deficiency and heart failure.
Phase:
Phase 4
Details
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Collaborators:
Charite University, Berlin, Germany Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) University of Göttingen